Browse Category

NASDAQ:DVLT News 23 January 2026

Datavault AI stock jumps again in premarket after 20% surge; DVLT back near $1

Datavault AI stock jumps again in premarket after 20% surge; DVLT back near $1

New York, Jan 23, 2026, 04:54 ET — Premarket Shares of Datavault AI Inc climbed 7.8% in premarket action Friday, reaching $0.967, following a 20.2% surge the day before. The Nasdaq-listed stock ended Thursday at $0.897, having traded between $0.743 and $0.907, with roughly 94 million shares exchanged. (Investing) This move stands out as Datavault is a low-priced stock known…

Stock Market Today

  • Oric Pharmaceuticals Shares Poised for 74% Upside as Biotech Innovation Draws Investor Attention
    January 23, 2026, 8:13 AM EST. Oric Pharmaceuticals (NASDAQ: ORIC) is gaining investor interest with a potential 74% upside from its current $12.05 share price, backed by partnerships with Pfizer, Bayer, and Johnson & Johnson. The clinical-stage biotech focuses on therapies addressing cancer treatment resistance, advancing candidates like ORIC-114 and ORIC-944 through early-stage trials. Despite a $1.17 billion market cap, Oric reports a negative EPS of -1.71 and free cash flow of -$70.7 million, reflecting typical high-risk biotech dynamics. With no dividends and a neutral RSI, stock momentum shows cautious optimism. Analysts rate ORIC with 14 buys and project a $21 average target price, suggesting substantial growth for investors able to tolerate the sector's inherent uncertainties.
Go toTop